Explore Research Innovation at UCLA Health
Our group has focused on prevention and treatment of valvular heart disease. Clinically, transcatheter valves have been offered at UCLA for aortic position (TAVR) since 2012 and for mitral position (Mitraclip) since 2015. With the clinical program, research projects have flourished from study prevention of disease to optimization of treatment techniques to novel valvular devices.
Several ongoing retrospective analyses are ongoing evaluating hemodynamic impact of intervention (TAVR or Mitraclip), optimization of conduction system during TAVR to lower risk of pacemaker, to aortic valve design for treatment of aortic valve regurgitation. In addition, we have been involved in multiple clinical trials for the TAVR procedure and enrolled patients over the years.
PI Contact information: email@example.com
Ravi Dave, MD
Marcella Calfon-Press, MD, PhD
Olcay Aksoy, MD
Andre Akhondi, MD
Ali Nsair, MD
A. Behi Rabbani, MD